• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    261.46 Down 4.23(1.59%) May 22, 4:00PM EDT
    |After Hours : 261.50 Up 0.04 (0.02%) May 22, 7:54PM EDT
    Add to Portfolio
    Prev Close:265.69
    Open:265.67
    Bid:N/A
    Ask:266.00 x 100
    1y Target Est:415.18
    Beta:-9
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:256.33 - 267.99
    52wk Range:128.50 - 349.08
    Volume:492,299
    Avg Vol (3m):646,691
    Market Cap:6.29B
    P/E (ttm):N/A
    EPS (ttm):-13.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ICPTDown 1.59%6.29B
    AZNDown 0.59%87.78B
    SLXP 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3,453.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.48
    Quarterly EPS Est (Jun-15) :-1.90
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-1.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback